胃食管反流病外科治疗后的并发症及其防治措施

路 源1, 李 晓峰2
1、青海大学医学院
2、青海大学附属医院普通外科三科

摘要


为探讨胃食管反流病外科治疗后的并发症及其防治措施，文章对胃食管反流病外科治疗后的常见并发症及
防治措施进行分析。常见并发症包括胃食管反流症复发、吞咽困难、气道症状、胃排空障碍、胃肠功能障碍等。针
对这些并发症，防治措施分别为改善术后胃食管反流症复发的预防措施、吞咽困难的防治措施、气道症状的预防与
处理、改善胃排空功能以及预防胃肠功能障碍。分析认为，了解并重视这些并发症及其防治措施，对提高胃食管反
流病外科治疗效果、改善患者预后具有重要意义。

关键词


胃食管反流病；外科治疗；并发症；防治措施

全文:

PDF


参考


[1]李英儒，刘付恒，陈双.胃食管反流病的外科治

疗策略[J].临床外科杂志，2024，32（09）：910-912.

[2]陈双，黄恩民，周太成.胃食管反流病的外科治

疗[J].外科理论与实践，2024，29（04）：292-295.

[3]克力木·阿不都热依木，王浩，麦麦提艾力·麦麦

提明.我国胃食管反流病外科治疗现状及展望[J].中国实

用外科杂志，2024，44（04）：395-397.

[4]卫锐狮，李新华，董胜利，等.胃食管反流病的

外科治疗研究最新进展[J].临床医药实践，2023，32（05）：

357-360.

[5]伊尔夏提江·艾尼瓦尔，亚力坤·吐尔洪，克力

木·阿不都热依木.肥胖与胃食管反流病的外科治疗研究

进展[J].腹腔镜外科杂志，2023，28（04）：301-305.

[6]Lin S,Chen Z,Jiang W, et al.Exploring esophagogastric

junction morphology and contractile integral: implications for

refractory gastroesophageal reflux disease pathophysiology[J].

Scandinavian Journal of Gastroenterology,2025,60(2):130-

135.

[7]Wang Q, Ma S, Liu M, et al.Gut microbiota,

inflammatory cytokines and gastro-esophageal reflux disease:

A Mendelian randomization analysis.[J].Medicine, 2025,

104(5): e41386.

[8]Lin S, Lai D, He W, et al.Causal relationship between

gastroesophageal reflux disease and chronic obstructive

respiratory disease: A bidirectional Mendelian randomization

study[J].Heliyon,2025,11(2):e42100-e42100.

[9]Kesavelu D, Franklyn N, Venkatraghavan C, et

al.Prevalence and Severity of Gastroesophageal Reflux Disease in

Indian Children Presenting with Symptoms of Acid Reflux: A

Real-world Evidence Study.[J].Turkish archives of pediatrics,2025.

[10]Yamamoto K, Inoue H, Tanaka I, et al.Utility

of endoscopic pressure study integrated system for

gastroesophageal reflux disease after endoscopic antireflux

therapy.[J].Digestive endoscopy: official journal of the Japan

Gastroenterological Endoscopy Society,2025,

[11]Dasgupta S. Unravelling genetic commonalities

between idiopathic pulmonary fibrosis and gastroesophageal

reflux disease: A bioinformatics exploration[J].Human Gene,

2025, 43201375-201375.

[12]Duncan R D, Liu E, Golden C, et al.Outcomes for

infants with BRUE diagnosed with oropharyngeal dysphagia

or gastroesophageal reflux disease: a multicenter study

from the Pediatric Health Information System Database.[J].

European journal of pediatrics,2025,184(2):134.

[13]Wickramasinghe N, Devanarayana M N. Unveiling

the intricacies: Insight into gastroesophageal reflux disease.[J].

World journal of gastroenterology,2025,31(1):98479.

[14]Ferrari D, Siboni S, Sozzi M, et al.The Milan

Score Predicts Objective Gastroesophageal Reflux Disease

in Patients With Type 2 Esophagogastric Junction.[J].

Neurogastroenterology and motility,2025,e14987.

[15]Kang H S, Moon S H, Sung K J, et al.Assessment

of the efficacy of on-demand tegoprazan therapy in

gastroesophageal reflux disease through a randomized

controlled trial[J].Scientific Reports,2025,15(1):168-168.

[16]Ishibashi F, Suzuki S, Mochida K, et al.Costeffectiveness analysis of endoscopic treatment versus

medication strategy for proton pump inhibitor-refractory

gastroesophageal reflux disease.[J].Digestion,2024,21-26.


Refbacks

  • 当前没有refback。